Anti-S22A8/ SLC22A8/ OAT3 monoclonal antibody

Anti-S22A8/ SLC22A8/ OAT3 antibody for FACS & in-vivo assay

Target products collectionGo to SLC22A8/SLC22A8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T70680-Ab-1/ GM-Tg-hg-T70680-Ab-2Anti-Human SLC22A8 monoclonal antibodyHuman
GM-Tg-rg-T70680-Ab-1/ GM-Tg-rg-T70680-Ab-2Anti-Rat SLC22A8 monoclonal antibodyRat
GM-Tg-mg-T70680-Ab-1/ GM-Tg-mg-T70680-Ab-2Anti-Mouse SLC22A8 monoclonal antibodyMouse
GM-Tg-cynog-T70680-Ab-1/ GM-Tg-cynog-T70680-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC22A8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T70680-Ab-1/ GM-Tg-felg-T70680-Ab-2Anti-Feline SLC22A8 monoclonal antibodyFeline
GM-Tg-cang-T70680-Ab-1/ GM-Tg-cang-T70680-Ab-2Anti-Canine SLC22A8 monoclonal antibodyCanine
GM-Tg-bovg-T70680-Ab-1/ GM-Tg-bovg-T70680-Ab-2Anti-Bovine SLC22A8 monoclonal antibodyBovine
GM-Tg-equg-T70680-Ab-1/ GM-Tg-equg-T70680-Ab-2Anti-Equine SLC22A8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T70680-Ab-1/ GM-Tg-hg-T70680-Ab-2; GM-Tg-rg-T70680-Ab-1/ GM-Tg-rg-T70680-Ab-2;
GM-Tg-mg-T70680-Ab-1/ GM-Tg-mg-T70680-Ab-2; GM-Tg-cynog-T70680-Ab-1/ GM-Tg-cynog-T70680-Ab-2;
GM-Tg-felg-T70680-Ab-1/ GM-Tg-felg-T70680-Ab-2; GM-Tg-cang-T70680-Ab-1/ GM-Tg-cang-T70680-Ab-2;
GM-Tg-bovg-T70680-Ab-1/ GM-Tg-bovg-T70680-Ab-2; GM-Tg-equg-T70680-Ab-1/ GM-Tg-equg-T70680-Ab-2
Products NameAnti-SLC22A8 monoclonal antibody
Formatmab
Target NameSLC22A8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-SLC22A8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species S22A8/ SLC22A8/ OAT3 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLV000246human SLC22A8 Lentivirus particle
    ORF Viral VectorpGMLV000246human SLC22A8 Lentivirus plasmid
    ORF Viral VectorpGMLPm004328mouse Slc22a8 Lentivirus plasmid
    ORF Viral VectorvGMLPm004328mouse Slc22a8 Lentivirus particle


    Target information

    Target IDGM-T70680
    Target NameSLC22A8
    Gene ID9376,19879,83500,718363,476049,101088955,100064251
    Gene Symbol and SynonymsOAT3,OCT3,Roct,SLC22A8
    Uniprot AccessionQ8TCC7,Q9R1U7
    Uniprot Entry NameS22A8_HUMAN,S22A8_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000149452
    Target ClassificationN/A

    The target: SLC22A8, gene name: SLC22A8, also named as OAT3. This gene encodes a protein involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and appears to be localized to the basolateral membrane of the kidney. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene. [provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.